A Study to Compare Meloxicam IM Once Daily and Meloxicam Administered Orally Once Daily in Patients With Osteoarthritis
Status:
Completed
Trial end date:
2004-12-01
Target enrollment:
Participant gender:
Summary
The objective of this trial was to assess the efficacy and safety of 7.5 mg meloxicam i.m.
once daily compared with 7.5 mg meloxicam tablets once daily p.o. in patients with
osteoarthritis over a time period of 7 days.